HPLC–FLD determination of serum aromatic amino acids: Application in chronic kidney disease patients
Authors:
- Ai-Guo TangATAi-Guo Tang
- Sa MuSMSa Mu
- 1 May 2011
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (11-12) , 1032-1035
Abstract
No abstract availableKeywords
Funding Information
- Science and Technological Department of Hunan Province (05SK3026)
- Public Health Department of Hunan Province (C2005019)
This publication has 24 references indexed in Scilit:
- Association of major depression and mortality in Stage 5 diabetic chronic kidney diseaseGeneral Hospital Psychiatry, 2010
- Determination of phenylalanine and tyrosine in plasma and dried blood samples using HPLC with fluorescence detectionJournal of Chromatography B, 2009
- Immunogenetic risk and protective factors for the development of L‐tryptophan–associated eosinophilia–myalgia syndrome and associated symptomsArthritis Care & Research, 2009
- More rapid and sensitive method for simultaneous determination of tryptophan and kynurenic acid by HPLCClinical Biochemistry, 2009
- Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptomsNephrology Dialysis Transplantation, 2009
- Quality of life and tryptophan levels in chronic renal failure patients on hemodialysisClinical Nephrology, 2008
- Impairment of phenylalanine conversion to tyrosine inend-stage renal disease causing tyrosine deficiencyKidney International, 2004
- Determination of Aromatic and Branched-Chain Amino Acids in Plasma by HPLC with Electrogenerated Ru(bpy)33+ Chemiluminescence DetectionChemical and Pharmaceutical Bulletin, 2003
- Amino acid metabolism in uremia.Journal of the American College of Nutrition, 1989
- Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.Journal of Clinical Investigation, 1980